Skip to main content

BoneSupport Holding

BoneSupport Holding AB is a Swedish medical technology company focused on the development and commercialization of injectable bio-resorbable bone graft substitutes. The company produces its proprietary CERAMENT technology platform, which promotes bone healing while delivering targeted local eluting antibiotics to treat bone voids and prevent infections. Principal revenue drivers consist of direct product sales of synthetic bone substitutes, associated surgical delivery instruments, and specialty clinical consumables. BoneSupport serves orthopedic surgeons, trauma centers, specialty hospitals, and surgical clinics across Europe, North America, and international markets. The company holds a distinct global market position as an innovator in antibiotic-eluting bone graft substitutes. BoneSupport Holding AB is headquartered in Lund, Sweden, and its common shares are listed on Nasdaq Stockholm.

26 of the funds FundTelligence covers report a position in BoneSupport Holding.

Legal name
BoneSupport Holding AB
Sector
Health Care
Country
Sweden
Funds holding it
26
Exposure themes
Ageing & Longevity, Healthy Ageing & Function, Mobility & Orthopaedics

Funds holding BoneSupport Holding

Showing the 8 largest of 26 funds holding it.

Loading...